Meeting everyday challenges: Antipsychotic therapy in the real world
- 30 September 2006
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 16, S156-S162
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Differential metabolic effects of antipsychotic treatmentsEuropean Neuropsychopharmacology, 2006
- Cognitive predictors of psychosocial functioning outcome in schizophrenia: A follow-up study of subjects participating in a rehabilitation programSchizophrenia Research, 2005
- Response and Relapse in Patients With Schizophrenia Treated With Olanzapine, Risperidone, Quetiapine, or HaloperidolThe Journal of Clinical Psychiatry, 2005
- Patients’ Opinions of Olanzapine and Risperidone Following Long-term Treatment: Results from a Cross-sectional SurveyPharmacopsychiatry, 2005
- Remission in Schizophrenia: Proposed Criteria and Rationale for ConsensusAmerican Journal of Psychiatry, 2005
- Randomized double blind comparison of olanzapine vs. clozapine on subjective well‐being and clinical outcome in patients with schizophreniaActa Psychiatrica Scandinavica, 2005
- Treatment of cognitive dysfunction in schizophreniaClinical Therapeutics, 2005
- Good tolerability equals good results: the patient’s perspectiveEuropean Neuropsychopharmacology, 2001
- Does Evidence From Clinical Trials in Psychopharmacology Apply in Clinical Practice?The Journal of Clinical Psychiatry, 2001
- Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.Neuropsychology, 1998